Literature DB >> 2172165

Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness.

M Jett1, W Brinkley, R Neill, P Gemski, R Hunt.   

Abstract

Arachidonic acid cascade products have been shown to be increased in vitro in Staphylococcus aureus enterotoxin B (SEB)-treated epithelial cell cultures in our laboratory. In order to confirm that these products were clinically related to SEB intoxication, monkeys were administered SEB by nasogastric intubation. It caused emesis in five of six monkeys (less than 4 h), and the sixth monkey showed signs of mild illness. The monkeys which vomited continued to display signs of gastrointestinal illness beyond 8 h but were without any apparent signs of illness by 24 h. Blood samples were collected prior to SEB administration, upon first indication of illness, and at twice that time interval. One week prior to SEB treatment, the same monkeys were administered saline by nasogastric intubation and in every way handled similarly in order to serve as their own controls. Blood samples were taken from the control animals at 0, 4, and 8 h. The plasma concentrations of prostaglandin E2 (PGE2), leukotriene B4 (LTB4), and 5-hydroxyeicosatetraenoic acid (5-HETE) did not vary significantly throughout the 8-h experiment for saline-treated controls, nor did they differ from the concentrations found in the plasma of monkeys just before administration of SEB. When the SEB-treated monkeys showed the first indication of illness (less than 4 h), the mean of the concentration in plasma of PGE2 increased 1.44-fold, that of LTB4 increased 2.23-fold, and that of 5-HETE was essentially unchanged. At twice the time interval of the first display of illness (less than 8 h), PGE2 was still elevated (1.48-fold), LTB4 had decreased slightly to 1.66-fold, and 5-HETE had soared (3,45-fold), suggesting a divergence in the enzymatic utilization of the parent compound of the latter two metabolites, 5-hydroperoxyeicosatetraenoic acid. These studies suggest that arachidonic acid cascade metabolites were a consequence of SEB intoxication and may provide a logical site for metabolic interference in SEB-induced toxicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172165      PMCID: PMC313688          DOI: 10.1128/iai.58.11.3494-3499.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Cysteinyl leukotrienes as mediators of staphylococcal enterotoxin B in the monkey.

Authors:  P H Scheuber; C Denzlinger; D Wilker; G Beck; D Keppler; D K Hammer
Journal:  Eur J Clin Invest       Date:  1987-10       Impact factor: 4.686

2.  Cell surface molecules involved in early events in T-cell mitogenic stimulation by staphylococcal enterotoxins.

Authors:  S M Vroegop; S E Buxser
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

Review 3.  Arachidonic acid metabolism.

Authors:  P Needleman; J Turk; B A Jakschik; A R Morrison; J B Lefkowith
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

4.  Staphylococcal enterotoxin gastroenteritis in rhesus monkeys.

Authors:  T H Kent
Journal:  Am J Pathol       Date:  1966-03       Impact factor: 4.307

Review 5.  Formation and actions of leukotrienes.

Authors:  P J Piper
Journal:  Physiol Rev       Date:  1984-04       Impact factor: 37.312

6.  Effect of staphylococcal enterotoxin B on cardiorenal functions and survival in X-irradiated rhesus macaques.

Authors:  C T Liu; M J Griffin; D E Hilmas
Journal:  Am J Vet Res       Date:  1978-07       Impact factor: 1.156

7.  Staphylococcal enterotoxin B as a nonimmunological mast cell stimulus in primates: the role of endogenous cysteinyl leukotrienes.

Authors:  P H Scheuber; C Denzlinger; D Wilker; G Beck; D Keppler; D K Hammer
Journal:  Int Arch Allergy Appl Immunol       Date:  1987

8.  Metabolism and analysis of cysteinyl leukotrienes in the monkey.

Authors:  C Denzlinger; A Guhlmann; P H Scheuber; D Wilker; D K Hammer; D Keppler
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

9.  Role of prostaglandins and cAMP in the secretory effects of cholera toxin.

Authors:  J W Peterson; L G Ochoa
Journal:  Science       Date:  1989-08-25       Impact factor: 47.728

10.  Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin.

Authors:  N A Soter; R A Lewis; E J Corey; K F Austen
Journal:  J Invest Dermatol       Date:  1983-02       Impact factor: 8.551

View more
  20 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Identification of a transcytosis epitope on staphylococcal enterotoxins.

Authors:  Jeffrey W Shupp; Marti Jett; Carol H Pontzer
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

Review 3.  The potential role of superantigens in inflammatory bowel disease.

Authors:  R A Kay
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

4.  Release of chromaffin granular content from staphylococcal enterotoxin B (SEB)-treated and -untreated PC12 cells.

Authors:  T Hase; M Jett; E Asafo-Adjei; M Topper
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

Review 5.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

6.  Immunity and responses of circulating leukocytes and lymphocytes in monkeys to aerosolized staphylococcal enterotoxin B.

Authors:  J Tseng; J L Komisar; J Y Chen; R E Hunt; A J Johnson; L Pitt; J Rivera; D L Ruble; R Trout; A Vega
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

7.  Identification of staphylococcal enterotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin.

Authors:  M Jett; R Neill; C Welch; T Boyle; E Bernton; D Hoover; G Lowell; R E Hunt; S Chatterjee; P Gemski
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.

Authors:  M Dohlsten; M Björklund; A Sundstedt; G Hedlund; D Samson; T Kalland
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

9.  Effects of staphylococcal enterotoxin B on rodent mast cells.

Authors:  J Komisar; J Rivera; A Vega; J Tseng
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

10.  Staphylococcal enterotoxin B initiates protein kinase C translocation and eicosanoid metabolism while inhibiting thrombin-induced aggregation in human platelets.

Authors:  Uyen Tran; Thomas Boyle; Jeffrey W Shupp; Rasha Hammamieh; Marti Jett
Journal:  Mol Cell Biochem       Date:  2006-03-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.